Symbol
UNCY on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership
1M shares
Security Ownership
5.7%
Shares, Excluding Options vs Price
Value, Excluding Options

Octagon Capital Advisors LP ownership in Unicycive Therapeutics, Inc. Common Stock, $0.001 par value (UNCY)

2025-11-14 - Octagon Capital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1M shares of Unicycive Therapeutics, Inc. Common Stock, $0.001 par value (UNCY). This represents 5.7% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.